- Home
- KROS vs INNV Comparison
KROS vs INNV Comparison
Compare KROS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- INNV
- Stock Information
- Founded
- KROS 2015
- INNV 2007
- Country
- KROS United States
- INNV United States
- Employees
- KROS N/A
- INNV N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- INNV Medical/Nursing Services
- Sector
- KROS Health Care
- INNV Health Care
- Exchange
- KROS Nasdaq
- INNV Nasdaq
- Market Cap
- KROS 565.0M
- INNV 485.4M
- IPO Year
- KROS 2020
- INNV 2021
- Fundamental
- Price
- KROS $15.71
- INNV $5.16
- Analyst Decision
- KROS Buy
- INNV Sell
- Analyst Count
- KROS 14
- INNV 3
- Target Price
- KROS $20.56
- INNV $5.00
- AVG Volume (30 Days)
- KROS 370.6K
- INNV 50.4K
- Earning Date
- KROS 11-05-2025
- INNV 11-04-2025
- Dividend Yield
- KROS N/A
- INNV N/A
- EPS Growth
- KROS N/A
- INNV N/A
- EPS
- KROS 0.47
- INNV N/A
- Revenue
- KROS $232,844,000.00
- INNV $853,699,000.00
- Revenue This Year
- KROS $5,998.31
- INNV $10.46
- Revenue Next Year
- KROS N/A
- INNV $10.50
- P/E Ratio
- KROS $33.68
- INNV N/A
- Revenue Growth
- KROS 85820.30
- INNV 11.76
- 52 Week Low
- KROS $9.12
- INNV $2.60
- 52 Week High
- KROS $72.37
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- KROS 53.11
- INNV 62.54
- Support Level
- KROS $15.00
- INNV $4.87
- Resistance Level
- KROS $16.57
- INNV $5.38
- Average True Range (ATR)
- KROS 0.53
- INNV 0.32
- MACD
- KROS -0.06
- INNV -0.01
- Stochastic Oscillator
- KROS 47.77
- INNV 81.67
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.